InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,064.20
(
0.91%
)
US TECH 100
17,185.60
(
0.64%
)
Dow Jones
38,225.66
(
0.85%
)
Brent Oil
83.60
(
-0.04%
)
Bitcoin
59,300.76
(
0.30%
)

Replies to post #136 on Adaptimmune Therapeutics PLC (ADAP)

Replies to #136 on Adaptimmune Therapeutics PLC (ADAP)

jondoeuk

05/09/21 6:43 PM

#138 RE: stockguard #136

At ASGCT they might show that their HiT targeting mesothelin has advantages over a comparative TRuC construct (similar to TCRR's) that was developed in-house.